Nascent Biotech Inc. (NBIO)
OTHER OTC:NBIO
US Market
Holding NBIO?
Track your performance easily

Nascent Biotech (NBIO) Income Statement

35 Followers

Nascent Biotech Income Statement

Last quarter (Q ), Nascent Biotech's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Nascent Biotech's net income was $-377.39K. See Nascent Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
---$ 1.00M$ 750.00K$ 0.00
Cost of Revenue
$ 432.44K$ 319.51K----
Gross Profit
$ -432.44K$ -319.51K-$ 1.00M$ 750.00K-
Operating Expense
$ 2.15M$ 2.23M$ 2.16M$ 1.46M$ 4.23M$ 3.45M
Operating Income
$ -1.90M$ -2.23M$ -2.16M$ -457.05K$ -3.48M$ -3.45M
Net Non Operating Interest Income Expense
$ -385.51K$ -379.97K$ -1.57M$ -48.00K$ -269.38K$ -86.63K
Other Income Expense
$ 2.04M$ 2.04M$ 2.77M$ -610.65K$ -778.60K$ -470.22K
Pretax Income
$ -1.86M$ -2.09M$ -6.12M$ 105.61K$ -2.97M$ -4.00M
Tax Provision
-----$ 0.00
Earnings From Equity Interest Net Of Tax
$ -2.09M$ -2.09M----
Net Income Common Stockholders
$ -2.26M$ -2.09M$ -6.12M$ 105.61K$ -2.97M$ -4.00M
Basic EPS
-----$ -0.12
Diluted EPS
----$ -0.01$ -0.12
Basic Average Shares
----$ 72.34M$ 34.39M
Diluted Average Shares
----$ 72.34M$ 34.39M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.58M$ 2.55M$ 2.16M$ 1.46M$ 4.23M$ 3.45M
Net Income From Continuing And Discontinued Operation
$ -2.26M$ -2.09M$ -2.80M$ 105.61K$ -2.97M$ -4.00M
Normalized Income
$ -3.78M$ -4.51M---$ -3.53M
Interest Expense
-----$ 86.63K
EBIT
$ -1.53M$ -1.70M$ -1.23M$ 153.61K$ -2.71M$ -3.92M
EBITDA
$ -1.30M$ -1.70M$ 114.35K$ 479.04K$ -2.77M$ -3.92M
Currency in USD

Nascent Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis